--- title: "A-share subscription | Techstorm opens subscription, its subsidiary product sales have ranked first in the world for three consecutive years" description: "Techstorm started its subscription on September 29, with an issue price of 5.98 yuan per share, a subscription limit of 27,500 shares, and a price-to-earnings ratio of 29.05 times. The company focuses" type: "news" locale: "en" url: "https://longbridge.com/en/news/259228751.md" published_at: "2025-09-28T23:26:02.000Z" --- # A-share subscription | Techstorm opens subscription, its subsidiary product sales have ranked first in the world for three consecutive years > Techstorm started its subscription on September 29, with an issue price of 5.98 yuan per share, a subscription limit of 27,500 shares, and a price-to-earnings ratio of 29.05 times. The company focuses on the research and production of new materials, with products covering fields such as wind power and new energy vehicles, and it ranked first globally in sales of epoxy resin for wind turbine blades from 2022 to 2024. CITIC Construction Investment Securities is its sponsor According to Zhitong Finance APP, on September 29, Techstorm (601026.SH) opened for subscription, with an issue price of 5.98 yuan per share, a subscription limit of 27,500 shares, and a price-to-earnings ratio of 29.05 times. It is listed on the Shanghai Stock Exchange, with CITIC Securities as its sponsor. The prospectus shows that Techstorm is a national high-tech enterprise dedicated to the research, production, and sales of new materials. During the reporting period, the company's products focused on high-performance thermosetting resin materials such as epoxy resin, polyurethane, acrylic ester, and organic silicon, forming three major product series: materials for wind turbine blades, resins for new composite materials, and adhesives for new energy vehicles and industrial applications. It provides a series of differentiated and refined new material product solutions for domestic and international customers in the fields of wind power, new energy vehicles, energy storage, hydrogen energy, as well as aviation, oil and gas extraction, electricity, and mold manufacturing. Through continuous independent research and development and technological innovation, Techstorm's epoxy resin products for wind turbine blades have basically achieved full coverage of mainstream wind turbine blade types. In 2024, the company's sales of "epoxy resin series for wind turbine blades" are expected to reach 143,100 tons, and sales of "structural adhesives for wind turbine blades" are expected to reach 15,200 tons. According to a letter issued by the China Petroleum and Chemical Industry Federation, from 2022 to 2024, the company's sales of "epoxy resin series for wind turbine blades" ranked first in the world. Meanwhile, the sales of "structural adhesives for wind turbine blades" ranked second in China and third globally. In recent years, Techstorm has continuously developed new products and is committed to expanding the application fields of its products. The new composite material resins can be widely used in the rail transit field for fiberglass/carbon fiber pultruded products, bolt sleeve embedded parts, carbon fiber sucker rods, mold manufacturing, and flame-retardant components, as well as in the construction materials field for carbon fiber aircraft seats and carbon fiber building reinforcement plates. Its clients include Chongqing Wind Crossing, Zhongfu Carbon Fiber, North Glass Institute, Tienshun Wind Power, Taishan Fiberglass, Guoxing Composite Materials, Haiyuan Composite Materials, and Zhenstone Group. New energy vehicle and industrial adhesives can be widely applied in the three-electric system of new energy vehicles, including motors, batteries, and electronic control components, as well as in sensors and other industrial fields. Current end customers include BYD Group, GAC Group, Geely Group, TE Connectivity, Hive Energy, Guoxuan High-tech, Envision Energy, Borui Electric, and Ganfeng Lithium Group. The funds raised from this issuance, after deducting issuance expenses, will be used for the following projects: ![image.png](https://imageproxy.pbkrs.com/https://img.zhitongcaijing.com/image/20250929/1759100695153703.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg) In terms of finance, for the fiscal years 2022, 2023, and 2024, the company achieved operating revenues of approximately 3.436 billion yuan, 3.202 billion yuan, and 3.238 billion yuan, respectively, with net profits of approximately 108 million yuan, 152 million yuan, and 155 million yuan during the same periods. ![image.png](https://imageproxy.pbkrs.com/https://img.zhitongcaijing.com/image/20250929/1759100516645157.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg) ### Related Stocks - [601026.CN - Techstorm](https://longbridge.com/en/quote/601026.CN.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Boralex Wins Contract for Difference for Sallachy Wind Farm in Scotland | Boralex Inc. has secured a UK government Contract for Difference for its Sallachy Wind Farm in Scotland, a 44 MW project | [Link](https://longbridge.com/en/news/276063631.md) | | REG - Tekmar Group PLC - £4m Contract for European Offshore Wind Project | Tekmar Group PLC has secured a £4 million contract for the supply of its 10th Generation Cable Protection Systems to a l | [Link](https://longbridge.com/en/news/275884880.md) | | PNE AG Receives Permits for Two New Wind Farms in Germany | PNE AG has received permits for two wind energy projects in Germany, under the German Federal Immission Control Act. The | [Link](https://longbridge.com/en/news/275437559.md) | | Montenegro clears environmental impact study for 118.8 MW Bijela wind farm | The Environmental Protection Agency of Montenegro has approved the environmental impact assessment for the 118.8 MW Bije | [Link](https://longbridge.com/en/news/275922496.md) | | US FDA approves labeling changes to menopause hormone therapies | The U.S. FDA has approved labeling changes for six menopause hormone therapies, removing warnings about cardiovascular d | [Link](https://longbridge.com/en/news/275790193.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.